Your browser doesn't support javascript.
loading
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study.
Al Sulaiman, Khalid; Badreldin, Hisham A; Korayem, Ghazwa B; Alenazi, Abeer A; Alsuwayyid, Faisal; Alrashidi, Abdulrahman; Alhijris, Mohammed; Almutairi, Faisal; Alharthi, Fahad; Vishwakarma, Ramesh; Al Shaya, Omar; Al Amri, Abdulrahman; Tayyab, Saqiba; Al Bekairy, Abdulkareem M; Aljuhani, Ohoud.
Afiliación
  • Al Sulaiman K; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Badreldin HA; Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia.
  • Korayem GB; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alenazi AA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alsuwayyid F; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alrashidi A; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alhijris M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Almutairi F; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia. gbkorayem@pnu.edu.sa.
  • Alharthi F; Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Vishwakarma R; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Al Shaya O; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Al Amri A; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Tayyab S; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Al Bekairy AM; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Aljuhani O; Statistics Department, European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Thromb J ; 20(1): 25, 2022 May 02.
Article en En | MEDLINE | ID: mdl-35501916
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Thromb J Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Thromb J Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido